We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Dual-Functional Fluorescent Probe for DNA Hybridization and Melting Point Analysis

By LabMedica International staff writers
Posted on 20 Aug 2013
Japanese researchers have described a new approach for combining real-time PCR amplification and melting curve analysis in a single-tube reaction, which provides a powerful means for new mutation detection assays.

This technology, which was jointly developed by the RIKEN Center for Life Science Technologies (Saitama, Japan) and K.K. More...
DNAFORM (Yokohama City, Japan) will enable the development of new, advanced assays for DNA-based genetic testing and should help to bring the benefits of genome-wide sequencing studies to patients in the clinic.

The new methodology is based on RIKEN's Eprobe, a highly efficient and reliable fluorescent probe. Eprobes contain two dye moieties attached to the same nucleotide, and their fluorescent signal is strongly suppressed as single-stranded oligonucleotides by an excitonic interaction between the dyes. Upon hybridization to a complementary DNA strand, the dyes are separated and intercalate into the double-strand leading to strong fluorescence signals. Furthermore, intercalation of dyes further stabilizes the DNA/DNA hybrid and increases the melting temperature compared to standard DNA oligonucleotides. Thus, Eprobes allow for specific real-time monitoring by amplification while enabling study of reaction products by melting curve analysis.

In a recent study, the investigators used Eprobes for the detection of genetic variations in a human EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) tumor. They demonstrated that Eprobes provided decisive advantages over commonly used hybridization probes because of their unique background signal reduction, enhanced DNA-binding affinity, and very low false positives rate.

"We are very excited about the potential of the new Eprobes,” said Dr. Matthias Harbers, a visiting scientist at the RIKEN Center for Life Science. "In the reactions, Eprobes acted like sequence-specific fluorescent dyes, which gives them great potential for use as hybridization probes not only in PCR and melting curve analysis but also in other important applications like, for instance, in fluorescent in situ hybridization or FISH."

The Eprobe study was published in the August 7, 2013, online edition of the journal PLOS ONE.

Related Links:

RIKEN Center for Life Science Technologies
K.K. DNAFORM



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.